Besides, we noticed that the transcriptional expression levels of FNDC6 varied depending on the tumor type, with lower levels in esophageal, breast, and prostate cancers and higher levels in lung and pancreatic cancers being found in some cases. This evidence concerns the gene IL20RB and prostate cancer.